Does Rallies track congressional trades in ILMN?

Yes. Rallies tracks politician and congressional stock disclosures for ILMN, including reported purchases, sales, dates, owners, and trade amounts when available.

Is ILMN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ILMN. It does not provide personalized investment advice.

ILMN (Illumina) Stock Analysis - Politician Trades

Illumina (ILMN) is a publicly traded Healthcare sector company. As of May 20, 2026, ILMN trades at $141.00 with a market cap of $21.41B and a P/E ratio of 25.43. ILMN moved +0.09% today. Year to date, ILMN is +5.46%; over the trailing twelve months it is +70.80%. Its 52-week range spans $68.70 to $156.66. Analyst consensus is neutral with an average price target of $141.42. Rallies surfaces ILMN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded ILMN stock?

Recent politician trading activity in ILMN includes disclosures from Gilbert Cisneros, Michael C. Burgess, Michael C. Burgess, and Thomas H. Kean. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

ILMN Key Metrics

Key financial metrics for ILMN
Metric	Value
Price	$141.00
Market Cap	$21.41B
P/E Ratio	25.43
EPS	$5.52
Dividend Yield	0.00%
52-Week High	$156.66
52-Week Low	$68.70
Volume	1.24M
Avg Volume	0
Revenue (TTM)	$4.39B
Net Income	$853.00M
Gross Margin	66.20%

Congressional Trades in ILMN

Gilbert Cisneros purchase ILMN on Feb 10, 2026 (amount: $15.00K).
Michael C. Burgess sale ILMN on Sep 3, 2024 (amount: $50.00K) for Spouse.
Michael C. Burgess sale ILMN on Aug 30, 2024 (amount: $50.00K).
Thomas H. Kean purchase ILMN on Apr 19, 2024 (amount: $15.00K).

Latest ILMN News

Illumina Cuts Packaging 87%, Hits 10 Genomes Per Minute Sequencing Pace — May 19, 2026
Illumina jumps as Q1 beat drives higher 2026 outlook and $1.5B buyback — May 4, 2026
Illumina jumps as Q1 results beat and 2026 outlook rises on NovaSeq X momentum — May 1, 2026
Illumina Q1 Revenue Climbs 4.8% to $1.09B; Authorizes $1.5B Buyback — Apr 30, 2026
Illumina jumps as traders position into Q1 2026 earnings due after close — Apr 30, 2026

Recent ILMN Insider Trades

Meister Keith A. sold 12.31K (~$1.77M) on May 14, 2026.
Meister Keith A. sold 52.78K (~$7.64M) on May 14, 2026.
Meister Keith A. sold 25.35K (~$3.71M) on May 14, 2026.

ILMN Analyst Consensus

12 analysts cover ILMN: 0 strong buy, 6 buy, 3 hold, 3 sell, 0 strong sell. Consensus rating is neutral. Average price target: $141.42.

Common questions about ILMN

Which politicians traded ILMN stock?: Recent politician trading activity in ILMN includes disclosures from Gilbert Cisneros, Michael C. Burgess, Michael C. Burgess, and Thomas H. Kean. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in ILMN?: Yes. Rallies tracks politician and congressional stock disclosures for ILMN, including reported purchases, sales, dates, owners, and trade amounts when available.
Is ILMN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ILMN. It does not provide personalized investment advice.